bromodeoxyuridine has been researched along with Mesothelioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramowski, V; Alekov, A; Giovannini, M; Hanemann, CO; Lerche, H; Utermark, T | 1 |
Fitzpatrick, DR; Marzo, AL; Robinson, BW; Scott, B | 1 |
2 other study(ies) available for bromodeoxyuridine and Mesothelioma
Article | Year |
---|---|
Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
Topics: Blotting, Western; Bromodeoxyuridine; Cell Division; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; DNA Primers; Enzyme Inhibitors; Humans; Immunoenzyme Techniques; Mesothelioma; Neoplasms, Mesothelial; Neurofibromatosis 2; Neurofibromin 2; Patch-Clamp Techniques; Polymerase Chain Reaction; Quinidine; Schwann Cells; Tumor Cells, Cultured | 2003 |
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
Topics: Animals; Bromodeoxyuridine; Cell Division; Female; Injections, Intralesional; Injections, Subcutaneous; Mesothelioma; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Oligonucleotides, Antisense; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured | 1997 |